Jyothi Nagajyothi, Ph.D. and her laboratory at the Hackensack Meridian Center for Discovery and Innovation (CDI) have identified what may be the main mechanism for how chronic Chagas disease, a ...

The combination of sacubitril and valsartan appeared superior to enalapril in the first randomized trial to generate high-quality evidence to support a drug treatment specifically for patients with ...

A simple imaging exam capable of assessing myocardial deformation during contraction has emerged as a promising tool for predicting the risk of cardiac complications in patients with chronic Chagas ...

Madrid, Spain – 1 September 2025: In patients with heart failure (HF) caused by Chagas disease, sacubitril/valsartan was superior to enalapril for the composite primary endpoint, predominantly driven ...

In patients with heart failure (HF) caused by Chagas disease, sacubitril/valsartan was superior to enalapril for the composite primary endpoint, predominantly driven by a significant reduction in ...

Please provide your email address to receive an email when new articles are posted on . Researchers in Brazil identified new echocardiographic parameters and biomarkers prognostic of poor cardiac ...

Researchers from one Washington, D.C., center confirmed that there was a high prevalence of Chagas disease in a sample of Latin American immigrants hospitalized with cardiac conditions. Of 97 adults ...